Beijing Winsunny Pharmaceutical CO.LTD (601089) — Net Asset Quality Index
Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Net Asset Quality Index of 76.5% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥4.69 Billion minus total liabilities of CN¥1.10 Billion yields net assets of CN¥3.59 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 601089 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Beijing Winsunny Pharmaceutical CO.LTD Net Asset Quality Index Over Time (2020–2024)
This chart shows how Beijing Winsunny Pharmaceutical CO.LTD's Net Asset Quality Index has evolved across 5 annual periods from 2020 to 2024. As of June 2025, the index stands at 76.5%, representing net assets of CN¥3.59 Billion against total assets of CN¥4.69 Billion CNY. Explore cash flow conversion of Beijing Winsunny Pharmaceutical CO.LTD to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
The table below presents the year-by-year Net Asset Quality Index for Beijing Winsunny Pharmaceutical CO.LTD from 2020 to 2024, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Beijing Winsunny Pharmaceutical CO.LTD worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 73.8% | CN¥3.56 Billion | CN¥4.82 Billion | CN¥1.26 Billion | ▼ -2.6 pp |
| 2023 | 76.4% | CN¥3.48 Billion | CN¥4.55 Billion | CN¥1.07 Billion | ▲ +2.9 pp |
| 2022 | 73.6% | CN¥3.18 Billion | CN¥4.32 Billion | CN¥1.14 Billion | ▲ +17.1 pp |
| 2021 | 56.4% | CN¥1.22 Billion | CN¥2.15 Billion | CN¥937.86 Million | ▼ -2.3 pp |
| 2020 | 58.7% | CN¥1.01 Billion | CN¥1.72 Billion | CN¥709.01 Million | — |